Impact of on-site cardiac catheterization on resource utilization and fatal and non-fatal outcomes after acute myocardial infarction

BMC Health Services Research

Volumn 6, Issue , 2006, Pages

  Halabi, Abdul R ^a   Beck, Christine A ^a   Eisenberg, Mark J ^b   Richard, Hugues ^a   Pilote, Louise ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRIC ACID DERIVATIVE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CANADA; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DATA BASE; ECHOCARDIOGRAPHY; EMERGENCY WARD; FATALITY; FEMALE; HEALTH CARE FACILITY; HEART CATHETERIZATION; HOSPITAL ADMISSION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHYSICIAN; POPULATION; TREADMILL EXERCISE; UNSTABLE ANGINA PECTORIS; ACUTE DISEASE; CLASSIFICATION; CORONARY ARTERY BYPASS GRAFT; CORONARY CARE UNIT; ECONOMICS; HEALTH CARE DELIVERY; HEART INFARCTION; HOSPITAL READMISSION; MIDDLE AGED; OUTCOME ASSESSMENT; PROPORTIONAL HAZARDS MODEL; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; UTILIZATION REVIEW;

ACUTE DISEASE; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOLOGY SERVICE, HOSPITAL; CORONARY ARTERY BYPASS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEART CATHETERIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT READMISSION; PROPORTIONAL HAZARDS MODELS; QUEBEC; TIME FACTORS;

EID: 33751528209     PISSN: 14726963     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-6-148     Document Type: Article

References (22)

1. Pilote L, Miller D, Califf R, Rao J, Weaver W, Topol E: Determinants of the use of coronary angiography and revascularization after thrombolysis for acute myocardial infarction in the United States. N Engl J Med 1996, 335:1198-1205.
2. Every N, Larson E, Litwin P, Maynard C, Fihn SD, Eisenberg MS, Hallstrom AP, Martin JS, Weaver D, for The Myocardial Infarction Triage and Intervention Project Investigators: The association between on-site cardiac catheterization facilities and the utilization of coronary angiography after acute myocardial infarction. N Engl J Med 1993, 329:546-551.
3. Behark S, Hod H, Benari B, Narinsky R, Pauzner H, Rechavia E, Faibel HE, Katz A, Roth A, Goldhammer E, Freedberg NA, Rougin N, Kracoff O, Shapira C, Jafari J, Lotan C, Daka F, Gottlieb S, Weiss T, Kanetti M, Klutstein M, Rudnik L, Barasch E, Mahul N, Blondheim D, Gelvan A, Barbash G: On-site catheterization laboratory and prognosis after acute myocardial infarction. Arch Intern Med 1995, 155:813-817.
4. Wright SM, Daley J, Peterson ED, Thibault GE, Outcomes of acute myocardial infarction in the Department of Veterans Affairs: Does regionalization of health care work? Med Care 1997, 35:128-141.
5. Every NR, Parsons LS, Fihn SD, Larson EB, Maynard C, Hallstrom AP, Martin JS, Weaver D: Long-term outcome in acute myocardial infarction patients admitted to hospitals with and without on-site cardiac catheterization facilities. Circulation 1997, 96:1770-1775.
6. Krumholz HM, Chen J, Murillo JE, Cohen DJ, Radford MJ: Admission to hospitals with on-site cardiac catheterization facilities. Impact on long-term costs and outcomes. Circulation 1998, 98:2010-2016.
7. Rogers WJ, Canto JG, Barron HV, Boscarino JA, Shoultz DA, Every NR: Treatment and outcome of myocardial infarction in hospitals with and without invasive capability. J Am Coll Cardiol 2000, 35:371-379.
8. Alter DA, Naylor CD, Austin PC, Tu JV: Long-term MI outcomes at hospitals with or without on-site revascularization. JAMA 2001, 285:2101-2108.
9. Yusuf S, Flather M, Pogue J, Hunt D, Varigos J, Piegas L, Avezum A, Anderson J, Keltai M, Budaj A, Fox K, Ceremuynski L, for the OASIS (Organisation to assess strategies for iscaemic syndromes) registry investigators: Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. Lancet 1998, 352:507-514.
10. Simoons M, Arnold A, Betriu A, De Buono DP, Col J, Dougherty FC, von Essen R, Lambertz H, Lubsen J, Meier B, et al.: Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty. Lancet 1988, 1:197-203.
11. Rogers WJ, Baim DS, Gore JM, Brown BG, Roberts R, Williams DO, Chesebro JH, Babb JD, Sheehan FH, Wackers FJT, Zaret BL, Robertson TL, Passamani ER, Ross R, Knatterud GL, Braunwald E: Comparison of immediate invasive, delayed invasive and conservative strategies after tissue-type plasminogen activator results of the Thrombolysis In Myocardial Infarction (TIMI) Phase II-A Trial. Circulation 1990, 81:1457-1476.
12. SWIFT Trial Study Group: SWIFT trial of delayed elective intervention vs conservative treatment after thrombolysis with anistreplase in acute myocardial infarction. Br Med J 1991, 302:555-560.
13. Williams D, Braunwald E, Knatterud G, Babb J, Bresnahan J, Greenberg MA, Raizner A, Wasserman A, Robertson T, Ross R: One-year results of the Thrombolysis in Myocardial Infarction Investigation (TIMI) Phase II trial. Circulation 1992, 85:533-542.
14. Barbash GI, Roth A, Hod H, Modan M, Miller HI, Rath S, Zahav YH, Keren G, Motro M, Shachar A, Basan S, Agranat O, Rabinowitz B, Laniado S, Kaplinsky E: Randomized controlled trial of late in-hospital angiography and angioplasty versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarction. Am J Cardiol 1990, 66:538-545.
15. Anderson H, Cannon C, Stone P, Williams D, McCabe C, Knatterud G, Thompson B, Willerson J, Braunwald E, for the TIMI IIIB investigators: One-year results of the thrombolysis in myocardial infarction (TIMI IIIB) clinical trial. J Am Coll Cardiol 1995, 26:1643-1650.
16. Boden W, O'Rourke R, Crawford M, Blausten A, Deedwania P, Zoble R, Wexler L, Kleiger R, Pepine C, Ferry D, Chow B, Lavori P, for the Veterans Affairs Non-Q Wave Infarction Strategies in Hospital (VANQWISH) Trial investigators: Outcomes in patients with acute non-Q wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. N Engl J Med 1998, 338:1785-1792.
17. Wallentin L, Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E: Outcome at 1 year after an invasive compared with a noninvasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. The Lancet 2000, 356:9-16.
18. Levy AR, Tamblyn RM, Fitchett D, McLeod PJ, Hanley JA: Coding accuracy of hospital discharge data for elderly survivors of myocardial infarction. Can J Cardiol 1999, 15:1277-1282.
19. Pilote L, Lavoie F, Ho V, Eisenberg M: Changes in the treatment and outcomes of acute myocardial infarction in Quebec, 1988-1995. Can Med Assoc J 2000, 163:31-36.
20. Tu JV, Naylor D, Austin P: Temporal changes in the outcomes of acute myocardial infarction in Ontario, 1992-1996. Can Med Assoc J 1999, 161:1257-1261.
21. Udvarhelyi IS, Gatsonis C, Epstein AM, Pashos CL, Newhouse JP, McNeil BJ: Acute myocardial infarction in the Medicare population. Process of care and clinical outcomes. JAMA 1992, 268:2530-2536.
22. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, Neumann F-J, Robertson DH, DeLucca PT, DiBattiste PM, Gibson M, Braunwald E: Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001, 344:1879-1887.